Disease/Condition | Definition |
---|---|
Recent severe myocardial infarction or cerebrovascular accident | < 6 months |
Cardiac failure, unless medically treated and not symptomatic | Â |
History or presence of any malignancy within the past 5 years, except for non-melanoma skin cancer. Subjects with ever history of testosterone (any hormone) dependent tumors. | Â |
Serious liver disease | ASAT, ALAT, AF, γGT >3 times upper limit of reference value (ASAT: 15–45 U/L; ALAT: 10–50 U/L; AF: 40–130 U/L ; γGT: 15–70 U/L: |
 | Central Laboratory, UMC Utrecht) |
Serious renal disease | Serum creatinine levels > 180 mol/L) |
Epilepsy (or the use of anti-epileptic medication) or migraine > once a month | Â |
Diabetes mellitus | Diagnosed by physician or fasting glucose level of 6.9 mmol/L or higher (capillary) |
Presence of any disease or condition that is clinically relevant and which might result in premature discontinuation, according to the opinion of the investigator. | Â |
Medication | Definition |
Corticosteroid use | Orally: <6 months ago in dosage >7.5 mg a day, with the exception of short bouts of prednisone for the period of 7 days. Inhalation: <6 months ago in the dosage of >800 g a day) |
 | Use of testosterone esters and alike substances within the past 60 days |
Conditions for which increase of androgen-like substances are contra-indicated | PSA levels: age 60–69 years >4.5 μg/l;70 years and over >6.5 μg/L |
 | Prostate hypertrophy in medical history Renal, liver function abnormalities or hematological abnormalities (Hb <7; Ht >0.50) |
 | Prostate or breast cancer |